{
 "PrintNo":"A4225","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-02-01T15:38:35.408983Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Alcoholism And Drug Abuse",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Alcoholism And Drug Abuse"}],
 "Actions":[
  {"Text":"REFERRED TO ALCOHOLISM AND DRUG ABUSE","Date":"2019-02-01","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO ALCOHOLISM AND DRUG ABUSE","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":484,"Name":"David Weprin","Short":"WEPRIN"}],
 "Title":"Relates to requiring the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment",
 "Summary":"Requires the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.",
 "LawSection":"Mental Hygiene Law","LawCode":"Amd ยง19.07, Ment Hyg L",
 "ActClause":"AN ACT to amend the mental hygiene law, in relation to requiring the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment",
 "PreviousVersions":["A8356-2015","A5459-2017"]
}